About The Medical Condition Drug Evaluation, FDA Phase II
Find the definition of the medical term Drug Evaluation, FDA Phase II. Drug Evaluation, FDA Phase II defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Drug Evaluation, FDA Phase II
| Drug Evaluation, FDA Phase II Medical Condition |
|---|
What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase II?
Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Vaccine, Bacterial ‐ Suspensions of attenuated or killed bacteria administered for…
- Biotyping, Mycological ‐ Procedures for identifying types and strains…
- Irrigation ‐ The washing of a body cavity or surface by flowing solution which…
- Horses ‐ Large, hoofed mammals of the family EQUIDAE. Horses are active…
- Poikiloderma Congenitale ‐ An autosomal recessive syndrome occurring principally in females,…
- Trichostomatina ‐ A suborder of ciliate protozoa characterized by non-reduction…
- Carotid Artery Injuries ‐ Blunt and penetrating traumatic injuries of the common, internal,…
- Antepartum CTG ‐ Monitoring of fetal heart frequency before birth in order to…
- Tachycardia, Reciprocal ‐ Condition marked by attacks of rapid action of the heart having…
- Neoplasms, Urethra ‐ Cancer or tumors of the URETHRA. This condition is relatively…